Skip to Main Content

Paper Details

Harnessing transcriptionally driven chromosomal instability adaptation to target therapy-refractory lethal prostate cancer.
Cell Rep Med
10
2023
Author NameAffiliation
Peiyao LiThomas Jefferson University, Sidney Kimmel Cancer Center
Rajesh K SoniMemorial Sloan Kettering Cancer Center
Ronald C HendricksonMemorial Sloan Kettering Cancer Center
Cora N SternbergEnglander Institute for Precision Medicine, Meyer Cancer Center, New York-Presbyterian Hospital
  • 1 - 4

Datasets

Release 1.2